-
Sector Analysis
NewHydrogen Transition Market Outlook and Trends, Deals, Contracts, Policies, Projects and Key Players, Q2 2024
Hydrogen Transition Market Report Overview The total active and pipeline capacity of low-carbon hydrogen projects is 204 mtpa as of March 2024, of which 92% comes from green plants and the remaining from blue plants. Many regions of the world with ample renewable resources are pursuing large-scale green hydrogen projects to capitalize on the falling cost of producing renewable energy. Furthermore, the pipeline of upcoming green projects represents 1,374 GW of electrolyzer capacity, while upcoming blue projects would incorporate over...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Durvalumab in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Durvalumab in Solid Tumor report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Durvalumab in Solid Tumor Drug Details: Durvalumab (MEDI-4736, Imfinzi, Fidursi, Imfinzio) a...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Rexlemestrocel-L in Hypoplastic Left Heart Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Rexlemestrocel-L in Hypoplastic Left Heart Syndrome report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Rexlemestrocel-L in Hypoplastic Left Heart Syndrome Drug Details: Rexlemestrocel-L is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Rexlemestrocel-L in Congestive Heart Failure (Heart Failure)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Rexlemestrocel-L in Congestive Heart Failure (Heart Failure) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Rexlemestrocel-L in Congestive Heart Failure (Heart Failure) Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Rexlemestrocel-L in Left Ventricular Dysfunction
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Rexlemestrocel-L in Left Ventricular Dysfunction report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Rexlemestrocel-L in Left Ventricular Dysfunction Drug Details: Rexlemestrocel-L is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ecubectedin in Soft Tissue Sarcoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Ecubectedin in Soft Tissue Sarcoma Drug Details: Ecubectedin (PM-14) is under development for the treatment...
-
Product Insights
Alopecia – Drugs In Development, 2023
Global Markets Direct’s, ‘Alopecia - Drugs In Development, 2023’, provides an overview of the Alopecia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Alopecia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Hematological Disorders Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Hematological Disorders Pipeline Market Report Overview The hematological disorders pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials. Key Segments ·       Hemostasis Tests ·       Coagulation Analyzers ·       Special Coagulation Tests ·       Hematology Tests ·       General Coagulation Tests Key...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – A-3907 in Primary Biliary Cholangitis (Primary Biliary Cirrhosis)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. A-3907 in Primary Biliary Cholangitis (Primary Biliary Cirrhosis) Drug Details: A-3907 is under development for...
-
Product Insights
Hematology Tests Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Hematology Tests Pipeline Market Report Overview Hematology tests include various blood tests that help diagnose and monitor various conditions. The Hematology Tests pipeline market research report provides comprehensive information about the Hematology tests pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that are in progress. Key Segments ·       Hemoglobin Point of Care (POC) Tests ·       Other Hematology Rapid Tests & POC ·       Platelets Point of Care (POC) Tests...